Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevork Wakimian

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|June 6, 2026
Phosphorylation-controlled nuclear speckle dynamics regulate splicingSuchismita Masanta, Kevork Wakimian, Maciej Cieśla
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quoAmani Yehya, Fatima Ghamlouche, Amin Zahwe, et al.
World Journal of Gastroenterology|September 26, 2022
Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional <i>in vitro</i> modelsAlissar Monzer, Kevork Wakimian, Farah Ballout, et al.
Pharmacological Reports : PR|November 17, 2024
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoidsAlissar Monzer, Fatima Ghamlouche, Kevork Wakimian, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|June 6, 2026
Phosphorylation-controlled nuclear speckle dynamics regulate splicingSuchismita Masanta, Kevork Wakimian, Maciej Cieśla
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quoAmani Yehya, Fatima Ghamlouche, Amin Zahwe, et al.
World Journal of Gastroenterology|September 26, 2022
Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional <i>in vitro</i> modelsAlissar Monzer, Kevork Wakimian, Farah Ballout, et al.
Pharmacological Reports : PR|November 17, 2024
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoidsAlissar Monzer, Fatima Ghamlouche, Kevork Wakimian, et al.
Pageof 1